ACKRELL CAPITAL Cannabis Investment Report | December 2017 for the issuance of separate licenses for cultivation and processing. It also contemplates that permits will be available under Colombia’s export laws for the export of lawful cannabis products to jurisdictions where importation is legal. Colombia issued the first processing license in 2016 and the first cultivation license in 2017. In 2017, Argentina enacted regulations permitting the use of cannabis oil and other derivatives either by qualifying patients or for scientific and medical research. Under the new legislation, the gov- ernment will oversee cultivation and production of cannabis and its derivatives for research purposes and for patient consumption, establish a national registry of qualifying patients and make cannabis products available to those patients, free of charge. The government expects to import cannabis sup- plies until they can be produced domestically. Other Latin American nations that have taken recent steps to increase medical cannabis access include Chile, Brazil, Mexico and Peru. In 2015, Chile changed its laws to allow medical cannabis use by patients and to authorize the sale of cannabis-based medicines through pharmacies. In 2016, Brazil approved. a resolution authorizing the prescription and importation of cannabis products, including THC and CBD, for use in treating certain qualifying medical conditions. In June 2017, Mexico enacted a law directing its Ministry of Health to prepare regulations for the research, production and medicinal use of “pharmacological derivatives” of cannabis. In November 2017, Peru adopted a bill legalizing the production, commercialization and importation of cannabis oil to be used for medical purposes. In the Caribbean region, Puerto Rico, the Cayman Islands and Jamaica have taken measures to decriminalize cannabis or increase access for medical use. In 2015, the governor of Puerto Rico signed an executive order that legalized use of cannabis der